REPORT – ERYTECH’S COMBINED SHAREHOLDERS’ MEETING ON JUNE 24, 2022 Post author:Marianne Duparc Post published:June 24, 2022 Post category:Newsroom ERYTECH Pharma announced that its Annual General Meeting was held on Friday, June 24, 2022. You Might Also Like ERYTECH Pharma completes the enrollment of patients in its Phase I clinical trial in pancreatic cancer June 27, 2011 ERYTECH TO RAISE €70.5 MILLION IN A PRIVATE PLACEMENT TO U.S. AND EUROPEAN INVESTORS April 13, 2017 ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer October 4, 2021
ERYTECH Pharma completes the enrollment of patients in its Phase I clinical trial in pancreatic cancer June 27, 2011
ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer October 4, 2021